Oak Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-89,935
| Closed | -$8.2M | – | 139 |
|
|
2025
Q2 | $8.2M | Buy |
89,935
+3,720
| +4% | +$360K | 0.54% | 40 |
|
|
2025
Q1 | $9.76M | Hold |
86,215
| – | – | 0.73% | 37 |
|
|
2024
Q4 | $9.11M | Sell |
86,215
-355
| -0.4% | -$38.1K | 0.63% | 38 |
|
|
2024
Q3 | $9.35M | Buy |
86,570
+527
| +0.6% | +$57.5K | 0.63% | 41 |
|
|
2024
Q2 | $9.34M | Sell |
86,043
-230
| -0.3% | -$27.1K | 0.62% | 40 |
|
|
2024
Q1 | $11.4M | Sell |
86,273
-490
| -0.6% | -$61.2K | 0.79% | 34 |
|
|
2023
Q4 | $10.6M | Sell |
86,763
-346
| -0.4% | -$38.6K | 0.8% | 37 |
|
|
2023
Q3 | $9.78M | Sell |
87,109
-713
| -0.8% | -$90.5K | 0.81% | 36 |
|
|
2023
Q2 | $12.8M | Sell |
87,822
-17,658
| -17% | -$2.4M | 1.02% | 29 |
|
|
2023
Q1 | $13.6M | Hold |
105,480
| – | – | 1.12% | 26 |
|
|
2022
Q4 | $13.4M | Sell |
105,480
-4,100
| -4% | -$476K | 1.13% | 29 |
|
|
2022
Q3 | $11.5M | Sell |
109,580
-14,476
| -12% | -$1.59M | 0.97% | 33 |
|
|
2022
Q2 | $13M | Sell |
124,056
-615
| -0.5% | -$73K | 1.02% | 32 |
|
|
2022
Q1 | $15.9M | Sell |
124,671
-4,798
| -4% | -$578K | 0.97% | 34 |
|
|
2021
Q4 | $16M | Sell |
129,469
-1,199
| -0.9% | -$157K | 0.85% | 34 |
|
|
2021
Q3 | $18.6M | Buy |
130,668
+1
| +0% | +$147 | 1.06% | 29 |
|
|
2021
Q2 | $20.4M | Sell |
130,667
-6
| -0% | -$972 | 1.15% | 25 |
|
|
2021
Q1 | $20.3M | Buy |
130,673
+7,046
| +6% | +$1.09M | 1.2% | 27 |
|
|
2020
Q4 | $18.5M | Buy |
123,627
+15,893
| +15% | +$2.24M | 1.12% | 29 |
|
|
2020
Q3 | $14.2M | Sell |
107,734
-2,024
| -2% | -$264K | 0.95% | 30 |
|
|
2020
Q2 | $12.7M | Buy |
109,758
+1,494
| +1% | +$172K | 0.85% | 36 |
|
|
2020
Q1 | $10.6M | Sell |
108,264
-1,447
| -1% | -$190K | 0.87% | 36 |
|
|
2019
Q4 | $15.9M | Sell |
109,711
-3,199
| -3% | -$442K | 0.94% | 38 |
|
|
2019
Q3 | $15M | Sell |
112,910
-808
| -0.7% | -$104K | 0.93% | 35 |
|
|
2019
Q2 | $13M | Buy |
+113,718
| New | +$13.3M | 0.81% | 37 |
|
|
2015
Q2 | – | Sell |
-17,201
| Closed | -$1.96M | – | 181 |
|
|
2015
Q1 | $1.96M | Hold |
17,201
| – | – | 0.24% | 91 |
|
|
2014
Q4 | $1.89M | Hold |
17,201
| – | – | 0.23% | 89 |
|
|
2014
Q3 | $1.68M | Hold |
17,201
| – | – | 0.21% | 94 |
|
|
2014
Q2 | $1.73M | Sell |
17,201
-3,914
| -19% | -$382K | 0.21% | 95 |
|
|
2014
Q1 | $1.94M | Hold |
21,115
| – | – | 0.24% | 86 |
|
|
2013
Q4 | $1.91M | Buy |
+21,115
| New | +$1.83M | 0.21% | 84 |
|
|
2013
Q2 | $2.14M | Buy |
+29,458
| New | +$2.2M | 0.26% | 67 |
|
Other funds holding ZBH
Oak Associates's ZBH Position: Q3 2025 in Review
Oak Associates sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 89,935 shares — an estimated $8.2M sold.
Oak Associates first reported a position in ZBH in Q2 2013 and held it in 32 quarters. The position peaked at $20.4M in Q2 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Oak Associates reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
- Oak Associates sold 89,935 Zimmer Biomet shares in Q3 2025, an estimated $8.2M.
- Oak Associates first reported a position in Zimmer Biomet in Q2 2013 and held it in 32 quarters.
- Oak Associates's Zimmer Biomet position peaked at $20.4M in Q2 2021.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Oak Associates's 13F filing for Q3 2025, filed 12 Nov 2025.